BR9508826A - Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico - Google Patents

Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico

Info

Publication number
BR9508826A
BR9508826A BR9508826A BR9508826A BR9508826A BR 9508826 A BR9508826 A BR 9508826A BR 9508826 A BR9508826 A BR 9508826A BR 9508826 A BR9508826 A BR 9508826A BR 9508826 A BR9508826 A BR 9508826A
Authority
BR
Brazil
Prior art keywords
nucleoside analogs
base attached
substituted benzimidazole
analogs containing
antiviral nucleoside
Prior art date
Application number
BR9508826A
Other languages
English (en)
Portuguese (pt)
Inventor
Leroy B Townsed
Susan Mary Daluge
Original Assignee
Wellcome Found
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/304,006 external-priority patent/US5534535A/en
Application filed by Wellcome Found, Univ Michigan filed Critical Wellcome Found
Publication of BR9508826A publication Critical patent/BR9508826A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9508826A 1994-09-09 1995-09-11 Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico BR9508826A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/304,006 US5534535A (en) 1992-03-09 1994-09-09 Therapeutic nucleosides
PCT/US1995/011366 WO1996007646A1 (en) 1994-09-09 1995-09-11 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring

Publications (1)

Publication Number Publication Date
BR9508826A true BR9508826A (pt) 1997-09-30

Family

ID=23174626

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9508826A BR9508826A (pt) 1994-09-09 1995-09-11 Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico

Country Status (17)

Country Link
EP (1) EP0779885A1 (cs)
JP (1) JPH10505092A (cs)
CN (1) CN1164855A (cs)
AP (1) AP741A (cs)
AU (1) AU3692895A (cs)
BR (1) BR9508826A (cs)
CA (1) CA2199502A1 (cs)
CZ (1) CZ71297A3 (cs)
FI (1) FI970959A7 (cs)
HU (1) HUT77440A (cs)
IS (1) IS4436A (cs)
NO (1) NO971070L (cs)
NZ (1) NZ294095A (cs)
OA (1) OA10601A (cs)
PL (1) PL319440A1 (cs)
SK (1) SK29197A3 (cs)
WO (1) WO1996007646A1 (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5912356A (en) * 1995-09-11 1999-06-15 Glaxo Wellcome Inc. Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
GB9600142D0 (en) * 1996-01-05 1996-03-06 Wellcome Found Chemical compounds
AU6221998A (en) 1997-02-13 1998-09-08 Glaxo Group Limited Benzimidazole derivatives
AU744176B2 (en) 1997-07-30 2002-02-14 Glaxo Group Limited Lyxofuranosyl benzimidazoles as antiviral agents
EP1162196A4 (en) 1999-12-27 2003-04-16 Japan Tobacco Inc COMPOUNDS WITH JOINED CYCLES AND THEIR USE AS MEDICAMENTS
US6770666B2 (en) 1999-12-27 2004-08-03 Japan Tobacco Inc. Fused-ring compounds and use thereof as drugs
GB0008939D0 (en) 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
AR035543A1 (es) * 2001-06-26 2004-06-16 Japan Tobacco Inc Agente terapeutico para la hepatitis c que comprende un compuesto de anillo condensado, compuesto de anillo condensado, composicion farmaceutica que lo comprende, compuestos de benzimidazol, tiazol y bifenilo utiles como intermediarios para producir dichos compuestos, uso del compuesto de anillo con
CN1834090B (zh) * 2005-03-18 2011-06-29 中国科学院上海药物研究所 苯并咪唑类化合物、其制备方法以及用途
EP2178880B1 (en) 2007-08-02 2017-10-04 Millennium Pharmaceuticals, Inc. Process for the synthesis of e1 activating enzyme inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9205071D0 (en) * 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
CA2199502A1 (en) 1996-03-14
EP0779885A1 (en) 1997-06-25
AP741A (en) 1999-04-26
FI970959A7 (fi) 1997-05-06
WO1996007646A1 (en) 1996-03-14
IS4436A (is) 1997-03-07
MX9701789A (es) 1997-10-31
AU3692895A (en) 1996-03-27
PL319440A1 (en) 1997-08-04
HUT77440A (hu) 1998-04-28
JPH10505092A (ja) 1998-05-19
NZ294095A (en) 1998-08-26
OA10601A (en) 2002-09-03
SK29197A3 (en) 1997-10-08
AP9700940A0 (en) 1997-04-30
FI970959A0 (fi) 1997-03-06
CZ71297A3 (en) 1997-08-13
NO971070L (no) 1997-05-07
NO971070D0 (no) 1997-03-07
CN1164855A (zh) 1997-11-12

Similar Documents

Publication Publication Date Title
FI935114A7 (fi) Rungosta modifioituja oligonukleotidianalogeja
NO950123L (no) PTH-analoger
CY2008001I2 (el) Antiviral compounds
IL92096A0 (en) Carboxylic nucleoside analogs
PT526253E (pt) Analogos do nucleosido 1,3-oxatiolano
FI906113A7 (fi) Viruksenvastaiset yhdisteet
FI911618A7 (fi) Parannuksia ruiskutuslaitteisiin
FI953794L (fi) N-Alkyyli-2-substituoidut ATP-analogit
FI945811A7 (fi) Des-Tyr-dynorfiinianalogeja
PT8904T (pt) Quadro de bicicleta
DK42490D0 (da) Melatoninanaloger
FI944134L (fi) Virustenvastaisia nukleosidianalogeja
BR9508826A (pt) Análogos de nucleosídeo antivirais contendo uma base de benzimidazol substituída ligada a um anel carboxílico
PT915819E (pt) Analogos de iludina uteis como agentes anti-tumorais
FI951798L (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
FI950535L (fi) Nukleosidianalogien stereoselektiivinen synteesi kaksirenkaista välituotetta käyttämällä
DK1165565T3 (da) Optisk rene camptothecin-analoger
FI883243A7 (fi) Purjelautojen puominkiinnitys
DK0428497T3 (da) Led til en knæledsstøtte
KR880016205U (ko) 추진력 증대를 위한 신축식 자전거 크랭크
IT8922546A0 (it) Accessorio per apparecchi sanitari
FI895572A7 (fi) Virusvastaisia yhdisteitä
ID946B (id) Alat untuk menggabungkan penahan bawah pada rantai ritsleting
FI923362A0 (fi) Järjestely hissijohteen kiinnittämiseksi johdealustaan
KR910011443U (ko) 자전거 원핸들 부착장치

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
FA8 Dismissal: dismissal - article 36, par. 1 of industrial property law